Successful Treatment of Recurrent Pustular Psoriasis of Pregnancy with Secukinumab: A Case Report

被引：9

作者：

Liu, Na ^{[1
,2
]}

Zhu, Lin ^{[1
]}

Cheng, Yuanyuan ^{[1
]}

Yu, Ning ^{[1
,2
]}

Yi, Xuemei ^{[1
,2
]}

Ding, Yangfeng ^{[1
,2
]}

机构：

[1] Tongji Univ, Sch Med, Shanghai Skin Dis Hosp, 1278 Baode Rd, Shanghai 200443, Peoples R China

[2] Tongji Univ, Sch Med, Inst Psoriasis, Shanghai, Peoples R China

来源：

ACTA DERMATO-VENEREOLOGICA | 2020年 / 100卷

关键词：

IMPETIGO HERPETIFORMIS;

D O I：

10.2340/00015555-3611

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Pustular psoriasis of pregnancy (PPP) is a challenging condition, which can have a serious effect on the life of a pregnant woman and her baby (1, 2). PPP is considered to be a rare form of generalized pustular psoriasis (1), which usually occurs in the third trimester and is characterized by desquamation, coalescent pustules, and systemic symptoms. Early recognition and treatment of PPP are of the utmost importance. Thus far, no standard treatment strategy has been developed for PPP, and the current treatment options are based on available case reports (3). We report here a case of a 37-year-old pregnant women with recurrent severe PPP who was treated successfully with secukinumab.

引用

页数：2

共 13 条

[1] Impetigo herpetiformis responsive to secukinumab [J].

Chhabra, Geetika ;

Chanana, Charvi ;

Verma, Prashant ;

Saxena, Ashok .

DERMATOLOGIC THERAPY, 2019, 32 (05)

[2] Secukinumab-induced paradoxical pustular psoriasis [J].

Dogra, S. ;

Bishnoi, A. ;

Narang, T. ;

Handa, S. .

CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2019, 44 (01) :72-73

[3] Certolizumab pegol for the treatment of psoriatic arthritis and plaque psoriasis [J].

Esposito, Maria ;

Carubbi, Francesco ;

Giunta, Alessandro ;

Alunno, Alessia ;

Giacomelli, Roberto ;

Fargnoli, Maria Concetta .

EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (02) :119-128

[4] Impetigo Herpetiformis during Pregnancy: A Case Report and Literature Review [J].

Gao, Qian-Qian ;

Xi, Ming-Rong ;

Yao, Qiang .

DERMATOLOGY, 2013, 226 (01) :35-40

[5] Impetigo Herpetiformis with Gestational Hypertension: A Case Report and Literature Review [J].

Huang, Y. H. ;

Chen, Y. P. ;

Liang, C. C. ;

Chang, Y. L. ;

Hsieh, C. C. .

DERMATOLOGY, 2011, 222 (03) :221-224

[6] Rebound pustular psoriasis after brodalumab discontinuation [J].

Khemis, A. ;

Cavalie, M. ;

Montaudie, H. ;

Lacour, J. -P. ;

Passeron, T. .

BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 (05) :1065-1066

[7] Impetigo herpetiformis with IL-36RN mutation successfully treated with secukinumab [J].

Kinoshita, Manao ;

Ogawa, Youichi ;

Takeichi, Takuya ;

Okamoto, Takashi ;

Osada, Atsushi ;

Shimada, Shinji ;

Sugiura, Kazumitsu ;

Akiyama, Masashi ;

Kawamura, Tatsuyoshi ;

Tsukamoto, Katsuhiko .

EUROPEAN JOURNAL OF DERMATOLOGY, 2018, 28 (03) :381-382

[8] Treatment resistant impetigo herpetiformis treated with infliximab [J].

Ogrum, Atiye ;

Takci, Zennure ;

Seckin, Havva Yildiz ;

Cetin, Elif .

DERMATOLOGIC THERAPY, 2019, 32 (02)

[9] Cyclosporine in the Management of Impetigo Herpetiformis: A Case Report and Review of the Literature [J].

Patsatsi, Aikaterini ;

Theodoridis, Theodoros D. ;

Vavilis, Dimitrios ;

Tzevelekis, Vasilios ;

Kyriakou, Aikaterini ;

Kalabalikis, Dimitrios ;

Sotiriadis, Dimitrios .

CASE REPORTS IN DERMATOLOGY, 2013, 5 (01) :99-104

[10]

Puig Lluis, 2018, Curr Probl Dermatol, V53, P49, DOI 10.1159/000479475

← 1 2 →